MODERN METHODS OF CHOLESTEROL MANAGEMENT

Cholesterol management is pivotal in mitigating cardiovascular disease, a leading global cause of mortality. This article explores contemporary strategies for controlling cholesterol levels, integrating pharmacological advancements, lifestyle interventions, precision medicine, and digital health technologies. Statins, PCSK9 inhibitors, bempedoic acid, and inclisiran offer robust LDL-C reduction, while Mediterranean and Portfolio diets, exercise, and behavioral interventions enhance holistic care. Precision medicine, leveraging genetic testing and polygenic risk scores, tailors treatments, and digital tools like mobile apps and AI-driven algorithms improve adherence and monitoring. Global disparities in access to advanced therapies and adherence challenges are significant barriers, particularly in low- and middle-income countries. Emerging approaches, including gene editing, microbiome modulation, and nanotechnology, promise future innovations. The article underscores the need for equitable, multidisciplinary strategies to optimize cholesterol management and reduce cardiovascular risk worldwide.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-31
DOI
https://doi.org/10.5281/zenodo.15558942
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MODERN METHODS OF CHOLESTEROL MANAGEMENT

Zenodo (CERN European Organization for Nuclear Research)
Lipoproteins and Cardiovascular Health
article

MODERN METHODS OF CHOLESTEROL MANAGEMENT

article en

Abstract

Cholesterol management is pivotal in mitigating cardiovascular disease, a leading global cause of mortality. This article explores contemporary strategies for controlling cholesterol levels, integrating pharmacological advancements, lifestyle interventions, precision medicine, and digital health technologies. Statins, PCSK9 inhibitors, bempedoic acid, and inclisiran offer robust LDL-C reduction, while Mediterranean and Portfolio diets, exercise, and behavioral interventions enhance holistic care. Precision medicine, leveraging genetic testing and polygenic risk scores, tailors treatments, and digital tools like mobile apps and AI-driven algorithms improve adherence and monitoring. Global disparities in access to advanced therapies and adherence challenges are significant barriers, particularly in low- and middle-income countries. Emerging approaches, including gene editing, microbiome modulation, and nanotechnology, promise future innovations. The article underscores the need for equitable, multidisciplinary strategies to optimize cholesterol management and reduce cardiovascular risk worldwide.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 36%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.